Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

What is the optimal international normalized ratio for patients undergoing catheter ablation of atrial fibrillation? Pick your poison (dose).

El Khoury ZH, Miller JM.

Circ Arrhythm Electrophysiol. 2013 Apr;6(2):239-40. doi: 10.1161/CIRCEP.113.000379. No abstract available.

2.

The optimal range of international normalized ratio for radiofrequency catheter ablation of atrial fibrillation during therapeutic anticoagulation with warfarin.

Kim JS, Jongnarangsin K, Latchamsetty R, Chugh A, Ghanbari H, Crawford T, Yokokawa M, Good E, Bogun F, Pelosi F Jr, Morady F, Oral H.

Circ Arrhythm Electrophysiol. 2013 Apr;6(2):302-9. doi: 10.1161/CIRCEP.112.000143. Epub 2013 Feb 26.

3.

Effectiveness of a strategy to reduce major vascular complications from catheter ablation of atrial fibrillation.

Abhishek F, Heist EK, Barrett C, Danik S, Blendea D, Correnti C, Khan Z, Ruskin JN, Mansour M.

J Interv Card Electrophysiol. 2011 Apr;30(3):211-5. doi: 10.1007/s10840-010-9539-8. Epub 2011 Feb 19.

PMID:
21336618
4.

Safety of ablation for atrial fibrillation with therapeutic INR: comparison with transition to low-molecular-weight heparin.

Saad EB, Costa IP, Costa RE, InĂ¡cio LA Jr, Slater C, Camiletti A, Moura Neto DG, Maldonado P, Camanho LE, Polanczky CA.

Arq Bras Cardiol. 2011 Oct;97(4):289-96. Epub 2011 Aug 19. English, Portuguese.

5.

Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.

Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, Lakkireddy D, Verma A, Khaykin Y, Hongo R, Hao S, Beheiry S, Pelargonio G, Dello Russo A, Casella M, Santarelli P, Santangeli P, Wang P, Al-Ahmad A, Patel D, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Cummings JE, Schweikert RA, Lewis WR, Natale A.

Circulation. 2010 Jun 15;121(23):2550-6. doi: 10.1161/CIRCULATIONAHA.109.921320. Epub 2010 Jun 1.

6.

Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period.

Wazni OM, Beheiry S, Fahmy T, Barrett C, Hao S, Patel D, Di Biase L, Martin DO, Kanj M, Arruda M, Cummings J, Schweikert R, Saliba W, Natale A.

Circulation. 2007 Nov 27;116(22):2531-4. Epub 2007 Nov 12.

7.

[Current state and perspectives of pharmacological and non-pharmacological treatment of atrial fibrillation: overview].

Okumura K.

Nihon Yakurigaku Zasshi. 2010 Feb;135(2):52-4. Review. Japanese. No abstract available.

PMID:
20154409
9.

Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment.

Hakalahti A, Uusimaa P, Ylitalo K, Raatikainen MJ.

Europace. 2011 May;13(5):640-5. doi: 10.1093/europace/eur038. Epub 2011 Mar 11.

PMID:
21398311
10.

Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.

Dentali F, Pignatelli P, Malato A, Poli D, Di Minno MN, Di Gennaro L, Rancan E, Pastori D, Grifoni E, Squizzato A, Siragusa S, Di Minno G, Ageno W.

Am J Hematol. 2012 Apr;87(4):384-7. doi: 10.1002/ajh.23119. Epub 2012 Feb 24. Erratum in: Am J Hematol. 2012 Jul;87(7):748. Grifoni, Elena [corrected to Grifoni, Elisa].

11.

Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.

Lakkireddy D, Reddy YM, Di Biase L, Vanga SR, Santangeli P, Swarup V, Pimentel R, Mansour MC, D'Avila A, Sanchez JE, Burkhardt JD, Chalhoub F, Mohanty P, Coffey J, Shaik N, Monir G, Reddy VY, Ruskin J, Natale A.

J Am Coll Cardiol. 2012 Mar 27;59(13):1168-74. doi: 10.1016/j.jacc.2011.12.014. Epub 2012 Feb 1.

12.

Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures.

Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Lappe DL, Muhlestein JB, Nelson J, Allison S, Foley T, Anderson L, Day JD.

J Cardiovasc Electrophysiol. 2009 Sep;20(9):988-93. doi: 10.1111/j.1540-8167.2009.01481.x. Epub 2009 May 15.

PMID:
19473299
13.

Safety of atrial fibrillation ablation with novel multi-electrode array catheters on uninterrupted anticoagulation-a single-center experience.

Hayes CR, Keane D.

J Interv Card Electrophysiol. 2010 Mar;27(2):117-22. doi: 10.1007/s10840-009-9457-9.

PMID:
20082132
14.

Effect of therapeutic INR on activated clotting times, heparin dosage, and bleeding risk during ablation of atrial fibrillation.

Gautam S, John RM, Stevenson WG, Jain R, Epstein LM, Tedrow U, Koplan BA, McClennen S, Michaud GF.

J Cardiovasc Electrophysiol. 2011 Mar;22(3):248-54. doi: 10.1111/j.1540-8167.2010.01894.x. Epub 2010 Aug 31.

PMID:
20812929
15.

A unique warfarin therapy in Japan.

Mitamura H.

Circ J. 2011;75(9):2048-9. Epub 2011 Aug 3. No abstract available.

16.

Which is the optimal therapy to prevent thromboembolism after atrial fibrillation ablation procedures in low stroke risk patients, anticoagulation or antiplatelet therapy?

Okumura Y.

J Cardiovasc Electrophysiol. 2009 Sep;20(9):994-6. doi: 10.1111/j.1540-8167.2009.01512.x. Epub 2009 Jun 22. No abstract available.

PMID:
19549032
17.

Efficacy and safety of periprocedural dabigatran in patients undergoing catheter ablation of atrial fibrillation.

Kaseno K, Naito S, Nakamura K, Sakamoto T, Sasaki T, Tsukada N, Hayano M, Nishiuchi S, Fuke E, Miki Y, Nakamura K, Yamashita E, Kumagai K, Oshima S, Tada H.

Circ J. 2012;76(10):2337-42. Epub 2012 Jun 30.

18.

Pharmacodynamic response to warfarin after conversion of atrial fibrillation or flutter to sinus rhythm.

Staats MC, Ernst ME.

Am J Health Syst Pharm. 2012 Jul 1;69(13):1158-61. doi: 10.2146/ajhp110609.

PMID:
22722595
19.

Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation.

Kwak JJ, Pak HN, Jang JK, Kim SK, Park JH, Choi JI, Hwang C, Kim YH.

J Cardiovasc Electrophysiol. 2010 Jun 1;21(6):620-5. doi: 10.1111/j.1540-8167.2009.01670.x. Epub 2009 Dec 21.

PMID:
20039992
20.

The effectiveness of warfarin dosing from a nomogram compared with house staff dosing.

Asnis PD, Gardner MJ, Ranawat A, Leitzes AH, Peterson MG, Bass AR.

J Arthroplasty. 2007 Feb;22(2):213-8.

PMID:
17275636

Supplemental Content

Support Center